MP72-13 SHIP-1 ACTIVATION PROVIDES SIGNIFICANT BENEFIT IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: RESULTS OF A PHASE 2 RANDOMIZED PLACEBO CONTROLLED TRIAL